UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 35

Sortiert nach

Oncobiome at the Forefront of a Novel Molecular Mechanism to Understand the Microbiome and Cancer

Translational Research and Onco-Omics Applications in the Era of Cancer Personal Genomics, 2019, Vol.1168, p.147-156

2019

Volltextzugriff (PDF)

Triggering receptor expressed on myeloid cells (TREM‐1) is regulated post‐transcriptionally and its ligand is present in the sera of some septic patients

Clinical and experimental immunology, 2006-09, Vol.145 (3), p.448-455

2006

Volltextzugriff (PDF)

Braf V600E mutation in melanoma: translational current scenario

Clinical & translational oncology, 2016-09, Vol.18 (9), p.863-871

2016

Volltextzugriff (PDF)

Braf V600E mutation in melanoma: translational current scenario

Clinical & translational oncology, 2016-09, Vol.18 (9), p.863-871

2016

Volltextzugriff (PDF)

RAPD markers associated with quercetin accumulation in Psidium guajava

Biologia plantarum, 2009-03, Vol.53 (1), p.125-128

2009

Volltextzugriff (PDF)

Abstract P2-11-10: Effect of supplementation with eicosapentaenoic and docosahexaenoic omega-3 polyunsaturated fatty acid on the chemotoxicity in Mexican patients with locally advanced breast cancer (LABC) treated with neoadjuvant chemotherapy (NeoCT)

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P2-P2-11-10

2017

Volltextzugriff (PDF)

A molecular analysis by gene expression profiling reveals Bik/NBK overexpression in sporadic breast tumor samples of Mexican females

BMC cancer, 2005-08, Vol.5 (1), p.93-93, Article 93

2005

Volltextzugriff (PDF)

Abstract P1-11-21: Effectiveness Analysis of Neoadjuvant Treatment by Using 4FE100C vs 6FE100C in Patients with Advanced Breast Cancer

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24_Supplement), p.P1-P1-11-21

2010

Volltextzugriff (PDF)

1150 POSTER Analysis of Biological Markers, Tumoral Predictors and Clinical Features as Prognosis Factors to Cnemotherapy Response in Metastatic Carcinomas of Unknown Primary Site

European journal of cancer (1990), 2011, Vol.47, p.S138-S139

2011

Volltextzugriff (PDF)

Is it possible to create human malignant cells in the laboratory?

Gaceta médica de México, 2000-03, Vol.136 (2), p.173

2000

Volltextzugriff (PDF)

Biomarker analysis by tissue microarray technology of Bik, Bcl-2, Bax, ER-α, ER-β, Her2/neu, PCNA, P53, pRB proteins and apoptotic index (by TUNEL) in breast cancer Mexican biopsies

Cancer research (Chicago, Ill.), 2009-01, Vol.69 (2_Supplement), p.4043

2009

Volltextzugriff (PDF)

5063 POSTER Improvement of Neoadjuvant Therapy Response by Using 4FE100C Vs 6FE100C in Locally Advanced Breast Cancer

European journal of cancer (1990), 2011, Vol.47, p.S349-S349

2011

Volltextzugriff (PDF)

6032 POSTER Colonic Tumour Localization, Clinicopathological Patterns and Incidence of Colorectal Carcinoma in Mexican Population

European journal of cancer (1990), 2011, Vol.47, p.S400-S401

2011

Volltextzugriff (PDF)

Proteomic analysis for NBK, Bcl-2, Bax genes and apoptosis (TUNEL) in breast cancer biopsies (stage II/III) by tissue microarray technology

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.22194-22194

2008

Volltextzugriff (PDF)

Association of the polymorphisms CYP19 (TTTA)n in treatment response to hormone therapy based in aromatase inhibitors in breast cancer patients

Cancer research (Chicago, Ill.), 2009-01, Vol.69 (2_Supplement), p.3033

2009

Volltextzugriff (PDF)

1101 POSTER Identification of KRas Mutational Polymorphism by Molecular Analysis Using High-resolution Melting System in a Large MCRC Mexican Sample

European journal of cancer (1990), 2011, Vol.47, p.S124-S125

2011

Volltextzugriff (PDF)

PCNA as potential marker for cervix neoplastic and preneoplastic lesions

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.16581-16581

2008

Volltextzugriff (PDF)

A phase II trial of the use of 4,4’-dihydroxybenzophenone-2,4-dinitrophenyl-hydrazone (A-007) topical gel in the treatment of high-grade squamous intraepithelial lesions (HSIL) of the cervix

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.5593-5593

2007

Volltextzugriff (PDF)

In situ polymerase chain reaction. New method for genetic diagnosis

Gaceta médica de México, 1998-11, Vol.134 (6), p.749

1998

Volltextzugriff (PDF)

Outcomes associated with retinoblastoma and c-myc gene expression in patients with testicular cancer: A ten-year experience

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.14656-14656

2006

Volltextzugriff (PDF)

Expression of telomerase enzyme as predictive factor of response to first line chemotherapy with gemcitabine/carboplatin in advanced non-small cell lung cancer (IIIB and IV)

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.17156-17156

2006

Volltextzugriff (PDF)

Telomerase activity in normal human breast and cancer, association with Bcl-2, estrogen receptors (α-, β-) and clinical parameters

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.9675-9675

2005

Volltextzugriff (PDF)

ORIGINAL ARTICLE: Triggering receptor expressed on myeloid cells (TREM-1) is regulated post-transcriptionally and its ligand is present in the sera of some septic patients

Clinical and experimental immunology, 2006-09, Vol.145 (3), p.448-455

2006

Volltextzugriff (PDF)

A molecular analysis by gene expression profiling reveals Bik/NBKoverexpression in sporadic breast tumor samples of Mexican females

BMC cancer, 2005-01, Vol.5

2005

Volltextzugriff (PDF)

Next Generation Sequencing (NGS): A Revolutionary Technology in Pharmacogenomics and Personalized Medicine in Cancer

Translational Research and Onco-Omics Applications in the Era of Cancer Personal Genomics, 2019, Vol.1168, p.9-30

2019

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(33)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(16)
Science & Technology
(16)
Oncology
(15)
Medicine, Research & Experimental
(12)
Research & Experimental Medicine
(12)
Humans
(5)
Cancer
(4)
Hematology, Oncology And Palliative Medicine
(4)
Personalized Medicine
(3)
Adult
(2)
Biomarker
(2)
Biomedical And Life Sciences
(2)
Cancer Research
(2)
Female
(2)
Genetics
(2)
Immunology
(2)
Life Sciences
(2)
Medicine
(2)
Melanoma
(2)
Middle Aged
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Oncobiome at the Forefront of a Novel Molecular Mechanism to Understand the Microbiome and Cancer

Triggering receptor expressed on myeloid cells (TREM‐1) is regulated post‐transcriptionally and its ligand is present in the sera of some septic patients

Braf V600E mutation in melanoma: translational current scenario

Braf V600E mutation in melanoma: translational current scenario

RAPD markers associated with quercetin accumulation in Psidium guajava

Abstract P2-11-10: Effect of supplementation with eicosapentaenoic and docosahexaenoic omega-3 polyunsaturated fatty acid on the chemotoxicity in Mexican patients with locally advanced breast cancer (LABC) treated with neoadjuvant chemotherapy (NeoCT)

A molecular analysis by gene expression profiling reveals Bik/NBK overexpression in sporadic breast tumor samples of Mexican females

Abstract P1-11-21: Effectiveness Analysis of Neoadjuvant Treatment by Using 4FE100C vs 6FE100C in Patients with Advanced Breast Cancer

1150 POSTER Analysis of Biological Markers, Tumoral Predictors and Clinical Features as Prognosis Factors to Cnemotherapy Response in Metastatic Carcinomas of Unknown Primary Site

Is it possible to create human malignant cells in the laboratory?

Biomarker analysis by tissue microarray technology of Bik, Bcl-2, Bax, ER-α, ER-β, Her2/neu, PCNA, P53, pRB proteins and apoptotic index (by TUNEL) in breast cancer Mexican biopsies

5063 POSTER Improvement of Neoadjuvant Therapy Response by Using 4FE100C Vs 6FE100C in Locally Advanced Breast Cancer

6032 POSTER Colonic Tumour Localization, Clinicopathological Patterns and Incidence of Colorectal Carcinoma in Mexican Population

Proteomic analysis for NBK, Bcl-2, Bax genes and apoptosis (TUNEL) in breast cancer biopsies (stage II/III) by tissue microarray technology

Association of the polymorphisms CYP19 (TTTA)n in treatment response to hormone therapy based in aromatase inhibitors in breast cancer patients

1101 POSTER Identification of KRas Mutational Polymorphism by Molecular Analysis Using High-resolution Melting System in a Large MCRC Mexican Sample

PCNA as potential marker for cervix neoplastic and preneoplastic lesions

A phase II trial of the use of 4,4’-dihydroxybenzophenone-2,4-dinitrophenyl-hydrazone (A-007) topical gel in the treatment of high-grade squamous intraepithelial lesions (HSIL) of the cervix

In situ polymerase chain reaction. New method for genetic diagnosis

Outcomes associated with retinoblastoma and c-myc gene expression in patients with testicular cancer: A ten-year experience

Expression of telomerase enzyme as predictive factor of response to first line chemotherapy with gemcitabine/carboplatin in advanced non-small cell lung cancer (IIIB and IV)

Telomerase activity in normal human breast and cancer, association with Bcl-2, estrogen receptors (α-, β-) and clinical parameters

ORIGINAL ARTICLE: Triggering receptor expressed on myeloid cells (TREM-1) is regulated post-transcriptionally and its ligand is present in the sera of some septic patients

A molecular analysis by gene expression profiling reveals Bik/NBKoverexpression in sporadic breast tumor samples of Mexican females

Next Generation Sequencing (NGS): A Revolutionary Technology in Pharmacogenomics and Personalized Medicine in Cancer

Suchergebnisse filtern